Vaccines - United Kingdom

Global Research & Data Services
April 18, 2011
SKU: GRDS6631232
Global Meningococcal Vaccines Market : 2014-2018
8/20/2014 | published by: TechNavio - Infiniti Research Ltd.
Press Release TechNavio Announces the Publication of its Research Report - Global Meningococcal Vaccines 2014-2018 TechNavio recognizes the following companies as the key players in the Global Meningococcal Vaccines: GlaxoSmithKline plc, Novartis AG and Sanofi Pasteur  |  read more...
USD 2,500
Vaccine Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
Vaccine Deals and Alliances of 2013 The Vaccine Deals and Alliances of 2013 provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013. Using  |  read more...
USD 1,495
VBI Vaccines - Product Pipeline Review - 2014
7/22/2014 | published by: Global Markets Direct
VBI Vaccines - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘VBI Vaccines - Product Pipeline Review - 2014’, provides an overview of the VBI Vaccines’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines
8/1/2014 | published by: Kelly Scientific Publications
PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines “PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing  |  read more...
USD 2,000
DNA Vaccines: Technologies and Global Markets
7/1/2014 | published by: BCC Research
DNA Vaccines: Technologies and Global Markets The global market for DNA vaccines was valued at $243.7 million in 2013 and is expected to increase to $305.3 million in 2014, and further to $2.7 billion  |  read more...
USD 6,650
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
7/14/2014 | published by: GlobalData
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020 Summary Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to  |  read more...
USD 5,995
Vaccine Partnering Terms and Agreements
7/1/2014 | published by: Current Partnering
Vaccine Partnering Terms and Agreements The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare  |  read more...
USD 2,995
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2
7/1/2014 | published by: MarketsandMarkets
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018  |  read more...
USD 4,650
China Animal Vaccine Industry Report, 2013-2016
7/1/2014 | published by: Research in China
China Animal Vaccine Industry Report, 2013-2016 China Animal Vaccine Industry Report, 2013-2016 by ResearchInChina covers the followings: The market size, market structure and competitive landscape of the global animal vaccine industry;  |  read more...
USD 2,500
Cancer Vaccines Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Cancer Vaccines Drug Pipeline Update 2014 Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has proved elusive, leaving  |  read more...
USD 6,746
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 654  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!